Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)
Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
This study will be investigating the effects of fesoterodine on autonomic dysreflexia (AD) in
patients with spinal cord injuries (SCI). The goal of the study is to examine the effect of
increasing daily use of fesoterodine on episodes of high blood pressure triggered by urinary
bladder contractions.
Phase:
Phase 2
Details
Lead Sponsor:
University of British Columbia
Collaborators:
International Collaboration On Repair Discoveries (ICORD) Pfizer Vancouver Coastal Health